Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/ajmg.a.37552 http://scihub22266oqcxt.onion/10.1002/ajmg.a.37552 26842671!ä!26842671 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Am+J+Med+Genet+A 2016 ; 170A (5): 1251-6 Nephropedia Template TP {{tp|p=26842671|t=2016. Clinical Report: Cognitive decline in a patient with Cardiofaciocutaneous syndrome |pdf=|usr=}}{{26842671}} gab.com Text Clinical Report: Cognitive decline in a patient with Cardiofaciocutaneous syndrome JO: Am J Med Genet A http://www.kidney.de/pget.php?&tw=1&pmid=26842671 #FOAvip Cardiofaciocutaneous Syndrome (CFCS) is a rare genetic syndrome caused by mutations in one of four genes: BRAF, MAP2K1, MAP2K2, and KRAS. There is tremendous phenotypic heterogeneity in patients with CFCS and so confirmation of diagnosis requires genetic testing. Neurologic and/or cognitive symptoms are present in almost all CFCS individuals. Little is known about cognitive function in older patients with CFCS. In this report, we present the cognitive, neuropsychiatric, and imaging findings of a patient diagnosed with CFCS who after having remained stable developed progressive cognitive/behavioral and motor decline. Twit Text FOAVip Clinical Report: Cognitive decline in a patient with Cardiofaciocutaneous syndrome ????Am J Med Genet A http://www.kidney.de/pget.php?&tw=1&pmid=26842671 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26842671 #FOAvip English Wikipedia <ref>{{Cite pmid|26842671}}</ref> Clinical Report: Cognitive decline in a patient with Cardiofaciocutaneous syndrome #MMPMID26842671 Cabrera S; Morel C; Tartaglia MC Am J Med Genet A 2016[May]; 170A (5): 1251-6 PMID26842671show ga Cardiofaciocutaneous Syndrome (CFCS) is a rare genetic syndrome caused by mutations in one of four genes: BRAF, MAP2K1, MAP2K2, and KRAS. There is tremendous phenotypic heterogeneity in patients with CFCS and so confirmation of diagnosis requires genetic testing. Neurologic and/or cognitive symptoms are present in almost all CFCS individuals. Little is known about cognitive function in older patients with CFCS. In this report, we present the cognitive, neuropsychiatric, and imaging findings of a patient diagnosed with CFCS who after having remained stable developed progressive cognitive/behavioral and motor decline. |Adult[MESH] |Baclofen/administration & dosage[MESH] |Brain/drug effects/pathology[MESH] |Cognitive Dysfunction/diagnostic imaging/drug therapy/genetics/*physiopathology[MESH] |Ectodermal Dysplasia/diagnostic imaging/drug therapy/genetics/*physiopathology[MESH] |Facies[MESH] |Failure to Thrive/diagnostic imaging/drug therapy/genetics/*physiopathology[MESH] |Heart Defects, Congenital/*diagnostic imaging/drug therapy/genetics/physiopathology[MESH] |Humans[MESH] |Male[MESH]Clinical Report: Cognitive decline in a patient with Cardiofaciocutane(epmc).pdf DeepDyve Pubget Overpricing